Social Media Ideas for Galderma

Galderma to buy US firm ZO Skin Health for $1.5 billion

Galderma Opens New Headquarters in Miami to Support US and Latin American Operations

The facility features a dedicated training space for healthcare professionals and supports the company’s long-term investment in the dermatology market.

Derm

Derm Anonymous (not verified) Wed, 10/07/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/derm.690595/ board name...

Blackstone inks $1.5bn sale of ZO Skin Health to Galderma

ZO Skin Health, founded by dermatologist Zein Obagi, generated about $330m in net sales in the 12 months to June and sells more than 40 products in over 40 countries. The post Blac...

<![CDATA[Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targ...

Pfizer’s eczema drug clears skin in mid-stage trial

Detailed results are competitive with Dupixent and Ebglyss, but the drug lacks differentiation amid an increasingly competitive landscape, one analyst argued.

Laboratoires Pierre Fabre appoints Zombré CEO of U.S. Dermocosmetics operations in Secaucus

Laboratoires Pierre Fabre, the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical groups, announced Aug. 25 the appointment of Nicolas Zombré...

<![CDATA[Roundup: GSK Acquires Trispecific T Cell-Engager from Chimagen, Sanofi & Cheplapharm Form Strategic Part...

Layoffs in Derm announced tomorrow

Layoffs in Derm announced tomorrow Anonymous (not verified) Wed, 10/21/2026 - 13:15 field_thread_url https://cafepharma.com/boards/threads/layoffs-in-derm-...

Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study

Roche is paying Hansoh $400 million up front in a broad deal involving several ADCs. Elsewhere, another top investor formed a China-focused fund and Ultragenyx sold a second review...

Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

- - • REGN20423, a clinical-stage long-acting IL-13 monoclonal antibody invented and developed by Regeneron, is added to the Alliance, along with a long-acting IL-4xIL-13 bispe...

<![CDATA[Roundup: Nanexa, Earendil Labs, and Atavistik Bio Enter Platform Deals with Novo Nordisk, Genentech, and Roc...

Dermata Therapeutics Announces Positive Topline Results from Cosmetic Study Evaluating Its Tome Foundational Treatment

- Once-weekly Tome Foundational Treatment demonstrated improvements across key measures of skin appearance after four treatments -- Over 71% of study participants were graded as ha...

Aesthetic Area Sales Directors

Aesthetic Area Sales Directors Anonymous (not verified) Fri, 10/23/2026 - 13:17 field_thread_url https://cafepharma.com/boards/threads/aesthetic-area-sales...

Galderma’s Relfydess Approved in China for Treatment of Frown Lines

The ready-to-use liquid botulinum toxin treatment requires no reconstitution. Phase III trials showed improvements in frown lines, with some patients maintaining results for up to...

Renova Pharmaceuticals launches its first three generic products

Renova Pharmaceuticals LLC, a Fairfield-based drug company focused on bringing high-quality and affordable generic medicines to patients, announced Sept. 11 the commercial launch o...

Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent

Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by t...

1,000,000,000 Billion Dollar Nemluvio Goal

1,000,000,000 Billion Dollar Nemluvio Goal Anonymous (not verified) Mon, 10/05/2026 - 04:07 field_thread_url https://cafepharma.com/boards/threads/1-000-0...

TADESO opens a new conversation on skin health with DWA-AT and Skin Atoz launch

TADESO Pharmaceutical Ventures, Inc. marked its entry into a new chapter in Philippine skin health with the launch of DWA-AT and Skin Atoz, bringing its Korean-developed dermatolog...

1,000,000,000 Billion Dollar Nemluvio Goal

1,000,000,000 Billion Dollar Nemluvio Goal Anonymous (not verified) Tue, 10/06/2026 - 04:08 field_thread_url https://cafepharma.com/boards/threads/1-000-0...

Sanofi and Cheplapharm to create new strategic partnership in mature medicines

Sanofi and Cheplapharm, a European leader in well-established medicines, today announced their intention to create a strategic partnership under which Cheplapharm would take over f...

<![CDATA[Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Ente...

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Fed. Circ. Backs Galderma In Injection Training IP Case

The Federal Circuit on Thursday affirmed an order clearing Galderma SA of a medical training startup's accusations that it misappropriated trade secrets related to an injection tra...